Showcase

公司名稱 Company Name

Wild Bird Therapeutics HK

公司網站 Company Website 

https://cancerappy.com/

公司簡介 Company Background
Wild Bird Therapeutics is a biotechnology company focused on the discovery and development of next-generation antibody-based therapeutics.
Wild Bird Therapeutics is an early-stage biotechnology company focused on developing next-generation antibody-based therapies for cancer. The company combines proprietary antibody assets with an AI-driven platform to accelerate drug discovery and optimization.Founded by a multidisciplinary team with expertise in biotechnology, computational science, and drug development, Wild Bird aims to bridge advanced research and translational application. The company is supported by international collaborations and is part of the HSITP ecosystem, where it is advancing its lead programs toward preclinical and IND-enabling stages.
陳列產品之簡介 Description of displayed product
Wild Bird Therapeutics presents a novel antibody-based therapeutic program supported by an AI-driven discovery platform. The displayed product includes a proprietary antibody with demonstrated in vivo efficacy, currently being developed toward an antibody-drug conjugate (ADC).Our platform integrates computational design and experimental validation to optimize targeting, internalization, and therapeutic performance. This approach accelerates the identification and development of high-potential drug candidates.The programme aims to advance the lead candidate through preclinical development, including pharmacology, safety evaluation, and IND-enabling studies, positioning it for future clinical translation in oncology.
公司產品 Company products